Researchers Launch COVID-19 Vaccine Study Based on Yellow Fever

In COVID-19, Latest News by Precision Vaccinations

A leading research institution located in Leuven, Belgium and Batavia Biosciences announced their partnership on the development of a vector-based COVID-19 vaccine candidate.
The virology team at the KU Leuven Rega Institute for Medical Research, which was founded in 1954, is headed by Prof. Dr. Johan Neyts, stated in a press release they ‘have developed a SARS-CoV-2 vaccine candidate consisting of an attenuated vector carrying the SARS-CoV-2 spike immunogen.’

Read More